For: | Piñero F, Marciano S, Fernández N, Silva J, Anders M, Zerega A, Ridruejo E, Romero G, Ameigeiras B, D’Amico C, Gaite L, Bermúdez C, Reggiardo V, Colombato L, Gadano A, Silva M. Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis. World J Gastroenterol 2019; 25(27): 3607-3618 [PMID: 31367160 DOI: 10.3748/wjg.v25.i27.3607] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i27/3607.htm |
Number | Citing Articles |
1 |
Federico Piñero, Marcelo Silva, Massimo Iavarone. Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitors. World Journal of Gastroenterology 2020; 26(16): 1888-1900 doi: 10.3748/wjg.v26.i16.1888
|
2 |
Claudia Maccali, Aline L. Chagas, Ilka Boin, Emilio Quiñonez, Sebastián Marciano, Mario Vilatobá, Adriana Varón, Margarita Anders, Sergio Hoyos Duque, Agnaldo S. Lima, Josemaría Menendez, Martín Padilla‐Machaca, Jaime Poniachik, Rodrigo Zapata, Martín Maraschio, Ricardo Chong Menéndez, Linda Muñoz, Diego Arufe, Rodrigo Figueroa, Alejandro Soza, Martín Fauda, Simone R. Perales, Rodrigo Vergara Sandoval, Carla Bermudez, Oscar Beltran, Isabel Arenas Hoyos, Lucas McCormack, Francisco Juan Mattera, Adrián Gadano, Jose H. Parente García, Claudia Megumi Tani, Luiz Augusto Carneiro D’Albuquerque, Flair J. Carrilho, Marcelo Silva, Federico Piñero. Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohort. Liver International 2021; 41(4): 851 doi: 10.1111/liv.14736
|
3 |
Cecilia C. Garcia, Bárbara Piotrkowski, Plácida Baz, Daniel Poncino, Javier Benavides, Luis Colombato, María Laura Reyes Toso, Silvina Yantorno, Valeria Descalzi, Gabriel E. Gondolesi, Cesar G. Fraga, Alejandra C. Cherñavsky. A Decreased Response to Resistin in Mononuclear Leukocytes Contributes to Oxidative Stress in Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2022; 67(7): 3006 doi: 10.1007/s10620-021-07105-z
|
4 |
Federico Piñero, Mario Tanno, Gabriel Aballay Soteras, Matías Tisi Baña, Melisa Dirchwolf, Eduardo Fassio, Andrés Ruf, Silvia Mengarelli, Silvia Borzi, Nora Fernández, Ezequiel Ridruejo, Valeria Descalzi, Margarita Anders, Guillermo Mazzolini, Virginia Reggiardo, Sebastián Marciano, Florencia Perazzo, Juan Carlos Spina, Lucas McCormack, Martín Maraschio, Cecilia Lagues, Adrián Gadano, Federico Villamil, Marcelo Silva, Fernando Cairo, Beatriz Ameigeiras. Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma. Annals of Hepatology 2020; 19(5): 546 doi: 10.1016/j.aohep.2020.06.003
|
5 |
Hong Zhao, Aiping Zhou, Jianguo Zhou, Xinyu Bi, Shida Yan, Jing Jin, Wenqiang Wei, Muxing Li, Caifeng Gong, Qichen Chen, Zhiwen Luo, Ning Li, Rui Mao, Xiao Chen, Bo Chen, Rongshou Zheng, Jianjun Zhao, Yue Han, Zhiyu Li, Xu Che, Yuan Tang, Yongkun Sun, Zhen Huang, Yefan Zhang, Xiaoying Wang, Yubao Zhang, Zhenhui Lu, Xiaowei Dang, Tianqiang Song, Chang Liu, Ping Yue, Dong Yan, Aimin Yue, Rui Zhang, Suxia Luo, Jing Tan, Xuewen Zhang, Xueli Bai, Xuejun Zhang, Mingyan He, Yujun Xie, Wenling Wang, Po Yang, Yijun Yang, Yamin Zhang, Qingdong Li, Tao Peng, Zusen Wang, Yajin Chen, Changzhen Shang, Yingjian Liang, Bixiang Zhang, Feng Zhang, Liming Wang, Duo Li, Bin Liu, Xiaofeng Zhu, Qinggang Hu, Minshan Chen, Dianrong Xiu, Feng Xia, Yanqiao Zhang, Yong Zeng, Yilei Mao, Xun Li, Yi Ba, Tingbo Liang, Feng Shen, Lianxin Liu, Xiujun Cai, Jian Zhou, Jianqiang Cai. Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey. HPB 2022; 24(3): 342 doi: 10.1016/j.hpb.2021.07.002
|
6 |
Juanfang Liu, Zhen Li, Wenguang Zhang, Huibin Lu, Zhanguo Sun, Guozheng Wang, Xinwei Han. Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.709060
|
7 |
Federico Piñero, Leonardo Gomes da Fonseca. Trial eligibility in advanced hepatocellular carcinoma: Does it support clinical practice in underrepresented subgroups?. World Journal of Gastroenterology 2021; 27(24): 3429-3439 doi: 10.3748/wjg.v27.i24.3429
|
8 |
Ying Jia, Yufei Xing, Meitian Yang, Muhammad Wasim Khan. Efficacy of Sorafenib Combined with Interventional Therapy on Primary Liver Cancer Patients and Its Effect on Serum AFP, VEGF, and GGT. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/9120265
|
9 |
Dung Thi Nguyen, Duong Hoang Nguyen, Van Thi Hong Nguyen. Sorafenib as first-line treatment for patients with primary hepatocellular carcinoma: an outcome evaluation. Journal of International Medical Research 2023; 51(6) doi: 10.1177/03000605231179928
|
10 |
Laura L de Guevara, Lucy Dagher, Vanessa MV Arruda, Keiko Nakajima, Masatoshi Kudo. Sorafenib Treatment by Child–Pugh Score in Latin American Patients with Hepatocellular Carcinoma. Future Oncology 2020; 16(31): 2511 doi: 10.2217/fon-2020-0323
|
11 |
Federico Piñero, Margarita Anders, Carla Bermudez, Ezequiel Demirdjian, Adriana Varón, Ana Palazzo, Jorge Rodriguez, Oscar Beltrán, Leonardo Gomes da Fonseca, Ezequiel Ridruejo, Pablo Caballini, Norberto Tamagnone, Virginia Reggiardo, Hugo Cheinquer, Alexandre Araujo, Diego Arufe, Juan Ignacio Marín, Natalia Ratusnu, Estela Manero, Daniela Perez, Marina Villa, Federico Orozco, Dolores Murga, Sebastián Marciano, Fernando Bessone, Marcelo Silva, Manuel Mendizabal. Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC. Annals of Hepatology 2023; 28(4): 101110 doi: 10.1016/j.aohep.2023.101110
|
12 |
Juan Ignacio Marín-Zuluaga, Juliana Vergara-Cadavid, Liliana Cajiao-Castro, Danny Arroyave-Zuluaga, Susana Castro-Sánchez, Laura Ceballos-Ramírez, Octavio Muñoz-Maya, Gabriel Sebastián Díaz-Ramírez. Caracterización, manejo y pronóstico de una cohorte de pacientes cirróticos con carcinoma hepatocelular. Hospital Pablo Tobón Uribe 2012-2018. Hepatología 2020; : 134 doi: 10.52784/27112330.121
|
13 |
Sami Akbulut, Ibrahim Umar Garzali, Abdirahman Sakulen Hargura, Ali Aloun, Sezai Yilmaz. Screening, Surveillance, and Management of Hepatocellular Carcinoma During the COVID-19 Pandemic: a Narrative Review. Journal of Gastrointestinal Cancer 2023; 54(2): 408 doi: 10.1007/s12029-022-00830-2
|